ABVC BioPharma vs Lexaria Bioscience
ABVC and LEXX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ABVC and LEXX compare
Lexaria Bioscience is the larger company, worth 4.3 times as much as ABVC BioPharma ($110M against $25.6M).
Lexaria Bioscience scores higher on the StockData Score (8 against 4 for ABVC BioPharma), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ABVC | LEXX |
|---|---|---|
| Size and price | ||
| Market cap | $25.6M | $110M |
| Share price | $0.960 | $4.44 |
| Change, 1 year | −66.8% | −74.0% |
| Change, 5 years | −97.1% | −94.7% |
| Beta (5Y) | 1.07 | 0.82 |
| Employees | 19 | 134 |
| StockData Score | ||
| Total score | 4 | 8 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 1 (better) | 0 |
| Health score | 2 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 567× |
| P/B | 2.0× (better) | 23.2× |
| FCF yield | – | −6.8% |
| Growth | ||
| Revenue growth (TTM) | – | −68.5% |
| Revenue growth, 5Y average | −9.3% | 17.5% (better) |
| Profitability | ||
| Gross margin | – | 100% |
| Operating margin | – | −3973% |
| Net margin | – | −3986% |
| FCF margin | – | −3849% |
| Return on equity | −31.2% (better) | −150% |
| Return on invested capital | −35.7% (better) | −602% |
| Financial health | ||
| Debt / equity | 0.00 (better) | 0.00 |
| Interest coverage | −34.5× | – |
| Current ratio | 0.20 | 10.60 (better) |
| Altman Z-score | −4.82 | 126.66 (better) |
| Piotroski F-score | 5 (better) | 2 |
| Dividends and buybacks | ||
| Buyback yield | – | −5.9% |
| Shareholder yield | 0.00% (better) | −5.9% |
| Ownership | ||
| Held by institutions | 4.1% | – |
| Held by insiders | 0.49% | 3.0% |
| Short interest, % of float | – | 0.90% |
Go deeper
- ABVC stock overview
- ABVC income statement
- ABVC valuation and score
- LEXX stock overview
- LEXX income statement
- LEXX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.